Basic Concepts and Indications of CAR T Cells

Area of Science:

• Immunology
• Oncology
• Biotechnology

Background:

• Chimeric antigen receptor (CAR) T cell therapy has transformed cancer immunotherapy, especially for hematological malignancies.
• This personalized treatment involves genetically modifying a patient's T cells to target cancer antigens, offering hope against refractory diseases.

Purpose of the Study:

• To provide a comprehensive overview of CAR T cell therapy.
• To discuss its fundamental concepts, clinical applications, and challenges in hematological malignancies.

Main Methods:

• Review of existing literature on CAR T cell therapy.
• Analysis of clinical applications and outcomes in hematological malignancies.

Main Results:

• CAR T cell therapy has shown high efficacy in previously untreatable hematological cancers.
• Significant challenges remain, including manufacturing complexity, toxicity management, resistance, and cost.

Conclusions:

• CAR T cell therapy is a powerful tool in cancer immunotherapy with a rapidly expanding clinical role.
• Ongoing research focuses on overcoming current challenges to improve long-term efficacy and accessibility.